EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Amitriptyline oral drops for the treatment of burning mouth syndrome: a case series of 13 patients

Gaetano Licata iD, Stefano Caccavale, Mariachiara Arisi, Cesare Ariasi iD, Caterina Mariarosaria Giorgio

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026-11 · 24 (11) · 1560-1563

DOI: 10.1111/ddg.70392 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 11.06.2026. Verfasst von Gaetano Licata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, San Antonio Abate Hospital, 91016, Trapani, Italy. Hauptthemen laut MEDLINE: Amitriptyline, Burning Mouth Syndrome. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Burning mouth syndrome (BMS) is a chronic oral neuropathic pain disorder. We conducted a retrospective case series of 13 postmenopausal women with primary BMS treated with low‐dose oral amitriptyline administered as liquid drops, allowing flexible titration to the individual minimum effective dose. Pain intensity was assessed using a visual analog scale (VAS), and quality of life was measured with the Dermatology Life Quality Index (DLQI) at baseline and during follow‐up (6–12 months). Mean baseline VAS was 7.4 and mean DLQI was 13.8. Clinically meaningful improvement was observed in 92.3% of patients, with complete remission in 6 cases and ≥50% pain reduction in 6 cases. Mean final VAS decreased to 1.7 and mean DLQI to 3.2. Symptomatic relief typically occurred within 2–4 weeks after reaching the effective dose and was maintained during follow‐up. Low‐dose amitriptyline administered with individualized titration appears to be a safe and effective option for refractory primary BMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmitriptylineBurning Mouth SyndromeHumansFemaleTreatment OutcomeAdministration, OralAgedMiddle AgedAnalgesics, Non-NarcoticPain MeasurementRetrospective StudiesDose-Response Relationship, Drug

Stichwörter der Autor:innen

Amitriptylineburning mouth syndrome

Substanzen

AmitriptylineAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Dermatology Unit, San Antonio Abate Hospital, 91016, Trapani, Italy.
  • Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, 80131, Naples, Italy.
  • Dermatology Department, ASST Spedali Civili di Brescia, University of Brescia, Brescia, Italy.

ORCID-Profile: Gaetano Licata, Cesare Ariasi

Zitieren

APA

Licata, G., Caccavale, S., Arisi, M., Ariasi, C., & Giorgio, C. M. (2026). Amitriptyline oral drops for the treatment of burning mouth syndrome: a case series of 13 patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 24(11), 1560-1563. https://doi.org/10.1111/ddg.70392

Vancouver

Licata G, Caccavale S, Arisi M, Ariasi C, Giorgio CM. Amitriptyline oral drops for the treatment of burning mouth syndrome: a case series of 13 patients. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026;24(11):1560-1563. doi:10.1111/ddg.70392

BibTeX
@article{Licata2026,
  author = {Licata, Gaetano and Caccavale, Stefano and Arisi, Mariachiara and Ariasi, Cesare and Giorgio, Caterina Mariarosaria},
  title = {Amitriptyline oral drops for the treatment of burning mouth syndrome: a case series of 13 patients},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2026},
  volume = {24},
  number = {11},
  pages = {1560--1563},
  doi = {10.1111/ddg.70392}
}
Kostenlos starten →